Loading
Zhejiang Hisun Pharmaceutical
Hisun is a large Chinese maker of active ingredients and generic injectables, founded in 1952 in Taizhou, whose biosimilar and generic cancer medicines go through the phase 3 trials it sponsors.
Also called: Zhejiang Hisun Pharmaceutical Co. Ltd.Hisun浙江海正药业
Overview
Zhejiang Hisun Pharmaceutical, headquartered in Taizhou, Zhejiang, and listed in Shanghai, is one of China's largest producers of active pharmaceutical ingredients and sterile injectables, including anthracyclines and other cytotoxics, and has moved into biosimilars such as adalimumab and bevacizumab. ClinicalTrials.gov lists Hisun as lead sponsor of a phase 3 cancer trial.
Connected
4Similar pages
- CompanyMabion
Shares Biosimilar, Pivotal (registrational) trial, Clinical trial.
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyImmunitor
- CompanyEmergent BioSolutions
- CompanyHarbour BioMed
- CompanyVion Pharmaceuticals
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
ClinicalTrials.gov · 1
hisunpharm.com · 1
wikidata.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/